AntiSomaGen is dedicated to providing Genomic and Proteomic services to assist its Biotechnology and Pharmaceutical partners in discovering, validating and developing new monoclonal antibodies, immunotherapic drugs, and novel biomakers associated with cancer for the improvement of human health.

• Monoclonal Antibodies
• Genomic Biomarkers
• Cancer Vaccines